Mumbai, July 9 -- Piramal Pharma announced that USFDA has issued an Establishment Inspection Report (EIR) for the company's manufacturing facility located at Sellersville (USA) and the inspection has now been successfully closed by USFDA.

Published by HT Digital Content Services with permission from Capital Market....